# Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia

> **NCT03679949** · PHASE1 · COMPLETED · sponsor: **New York State Psychiatric Institute** · enrollment: 26 (actual)

## Conditions studied

- Pain
- Abuse, Drug

## Interventions

- **DRUG:** Oxycodone
- **DRUG:** Cannabis (THC:CBD = ~ 1:0)
- **DRUG:** Cannabis (THC:CBD = ~ 0:1)
- **DRUG:** Cannabis (THC:CBD = ~ 1:1)
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03679949
- **Lead sponsor:** New York State Psychiatric Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-04-01
- **Primary completion:** 2022-12-06
- **Final completion:** 2022-12-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2024-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03679949

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03679949, "Effects of Cannabis on Prescription Drug Abuse Liability and Analgesia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03679949. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*